Please login to the form below

Not currently logged in


This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

AZ, Amgen’s investigational asthma drug comes good in phase 3

AZ, Amgen’s investigational asthma drug comes good in phase 3

The phase 3 NAVIGATOR trial evaluated tezepelumab plus standard of care, which included medium- or high-dose inhaled corticosteroids (ICS) plus at least one controller medication, with or without oral corticosteroids

Latest news

More from news
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

  • The roaring ‘20s and Generation Z The roaring ‘20s and Generation Z

    For instance, the draft NHS Standard Contract 2020/21, published in December 2019 will see NHS Trusts and CCGs being contractually obliged to work collectively as a single local ICS system, ... Over the next five years at least, campaigns and messaging

  • NHS regional footprints NHS regional footprints

    CCGs in action. In Nottinghamshire, six CCGs have joined forces to lead the strategic development of integrated care within the geographical area originally allocated to the Nottinghamshire ICS.

  • Deal Watch table for August 2014 Deal Watch table for August 2014

    600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Delivering true value: what does it mean for KAM in cancer care?

    The real challenge of working with these new ICS accounts and other integrated care organisations is very much about teamwork.

  • How will the Tories’ historic win shape the NHS?

    Integrated care. The Tories’ win has provided assurance that there will be 100 percent Integrated Care System (ICS) coverage across England by April 2021, as promised in the Long-term Plan. ... We wait to see if it will mean a growth in CCG and ICS

  • 2019: A pivotal year for the NHS

    Structure. The Long-term Plan stated that, by April 2021, all areas of England will be covered by an Integrated Care System (ICS), with typically just one Clinical Commissioning Group (CCG) ... It means that hospitals and CCGs must now work together to

  • Early diagnosis underpins NHS cancer strategy

    The Cancer Alliances will advise Sustainability and Transformation Partnership (STP) and Integrated Care System (ICS) board members on cancer services and help to ensure that local cancer strategies are delivered.

  • What role for pharma in helping to deliver integrated care?

    Phil explained how Dorset ICS runs “a family budgeting system”, where money has already moved from one organisation to another to achieve balance across the system. ... To hear more from Dr Phil Richardson, of Dorset ICS, regarding integrated care

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...